AMOXICILLIN for Oral Suspension USP, 400MG/5ML, 100ML (when reconstituted), Manufactured In Canada By: TEVA CANA LIMITED, Toronto, Canada M1B 2K9; Manufactured For: TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454. NDC: 0093-4161-73
Published January 3, 2024 · Recall initiated: January 26, 2022
Summary
FDA records drug Class II recall D-0165-2024, published January 3, 2024 and initiated January 26, 2022. Recalling firm: CARDINAL HEALTHCARE; Status: Terminated; Reported quantity: 3 units; Lot: Batch 35447184A. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
What to do
Voluntary: Firm initiated · Letter
Get an email if AMOXICILLIN has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- AMOXICILLIN
- Manufacturer
- CARDINAL HEALTHCARE
- Distributor
- Nationwide USA
- UPC
- 0300933107051
- Lot
- Batch 35447184A
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAAMOXICILLIN Tablets, USP, 875MG, 20 Tablets, Rx Only, Manufactured by Sandoz GmbH for Sandoz Inc., Princeton,January 3, 2024
- FDAALLOPURINOL Tablets, USP 300 MG 500 count Tablets per bottle, Rx only, Manufactured By: Dr. Reddy'sJanuary 3, 2024
- FDAALBUTEROL SULFATE IN 90MCG per actuation, 200 Metered Inhalations, Rx Only, 8.5 g Net Contents, ManufacturedJanuary 3, 2024
- FDAAmoxicillin Capsules, USP, 500 mg, 100-count bottle, Rx only, MFG: Sandoz Pharma, NDC 0781-2613-01June 15, 2022
- FDAAmoxicillin for Oral suspension, USP 400 mg/5 mL, 100 mL (when reconstituted), Rx only, Manufactured by: HikmaNovember 30, 2016
- FDAAmoxicillin for Oral Suspension USP, 400 mg/ 5 mL, 50 mL bottle, Rx only, Manufactured In Canada by: TevaAugust 31, 2016
Questions about this recall
Was AMOXICILLIN for Oral Suspension USP, 400MG/5ML, 100ML (when reconstituted), Manufactured In Canada By: TEVA CANA LIMITED, Toronto, Canada M1B 2K9; Manufactured For: TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454. NDC: 0093-4161-73 recalled?
Yes. FDA published recall D-0165-2024 on January 3, 2024. Reported hazard: CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: AMOXICILLIN. UPC: 0300933107051.